AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 18.5 USD 0.76% Market Closed
Market Cap: 820.3m USD

AxoGen Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AxoGen Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
AxoGen Inc
NASDAQ:AXGN
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Non-Reccuring Items
-$480m
CAGR 3-Years
-13%
CAGR 5-Years
0%
CAGR 10-Years
-36%
Boston Scientific Corp
NYSE:BSX
Non-Reccuring Items
-$402m
CAGR 3-Years
24%
CAGR 5-Years
-6%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Non-Reccuring Items
-$1.4B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-3%
Abbott Laboratories
NYSE:ABT
Non-Reccuring Items
-$350m
CAGR 3-Years
-29%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

AxoGen Inc
Glance View

Market Cap
816.8m USD
Industry
Health Care

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

AXGN Intrinsic Value
11.74 USD
Overvaluation 37%
Intrinsic Value
Price

See Also

Back to Top